EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Mechanism of epithelial‐mesenchymal transition in cancer and its regulation by natural compounds

Hui Li Ang, Chakrabhavi Dhananjaya Mohan, Muthu K Shanmugam, Hin Chong Leong, Pooyan Makvandi, Kanchugarakoppal S Rangappa iD, Anupam Bishayee iD, Alan Prem Kumar iD, Gautam Sethi iD

Medicinal Research Reviews · 2023-07 · 43 (4) · 1141-1200

DOI: 10.1002/med.21948 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Medicinal Research Reviews, online erschienen am 17.03.2023. Verfasst von Hui Li Ang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore. Hauptthemen laut MEDLINE: Epithelial-Mesenchymal Transition, Neoplasms. Die Arbeit wurde bisher 226-mal zitiert (Crossref) und nennt 464 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Epithelial‐mesenchymal transition (EMT) is a complex process with a primordial role in cellular transformation whereby an epithelial cell transforms and acquires a mesenchymal phenotype. This transformation plays a pivotal role in tumor progression and self‐renewal, and exacerbates resistance to apoptosis and chemotherapy. EMT can be initiated and promoted by deregulated oncogenic signaling pathways, hypoxia, and cells in the tumor microenvironment, resulting in a loss‐of‐epithelial cell polarity, cell–cell adhesion, and enhanced invasive/migratory properties. Numerous transcriptional regulators, such as Snail, Slug, Twist, and ZEB1/ZEB2 induce EMT through the downregulation of epithelial markers and gain‐of‐expression of the mesenchymal markers. Additionally, signaling cascades such as Wnt/β‐catenin, Notch, Sonic hedgehog, nuclear factor kappa B, receptor tyrosine kinases, PI3K/AKT/mTOR, Hippo, and transforming growth factor‐β pathways regulate EMT whereas they are often deregulated in cancers leading to aberrant EMT. Furthermore, noncoding RNAs, tumor‐derived exosomes, and epigenetic alterations are also involved in the modulation of EMT. Therefore, the regulation of EMT is a vital strategy to control the aggressive metastatic characteristics of tumor cells. Despite the vast amount of preclinical data on EMT in cancer progression, there is a lack of clinical translation at the therapeutic level. In this review, we have discussed thoroughly the role of the aforementioned transcription factors, noncoding RNAs (microRNAs, long noncoding RNA, circular RNA), signaling pathways, epigenetic modifications, and tumor‐derived exosomes in the regulation of EMT in cancers. We have also emphasized the contribution of EMT to drug resistance and possible therapeutic interventions using plant‐derived natural products, their semi‐synthetic derivatives, and nano‐formulations that are described as promising EMT blockers.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Epithelial-Mesenchymal TransitionNeoplasmsHumansPhosphatidylinositol 3-KinasesHedgehog ProteinsTranscription FactorsCell Line, TumorGene Expression Regulation, NeoplasticTumor Microenvironment

Stichwörter der Autor:innen

EMT-related transcription factorsinvasion and migrationmetastasis promoting signaling pathwaysnoncoding RNAs in EMT regulationtumor-derived exosomestype 3 EMT

Substanzen

Phosphatidylinositol 3-KinasesHedgehog ProteinsTranscription Factors

Autor:innen und Institutionen

  • Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
  • Department of Studies in Molecular Biology, University of Mysore, Manasagangotri, Mysore, Karnataka, India.
  • Istituto Italiano di Tecnologia Centre for Materials Interface, Pontedera, Pisa, Italy.
  • Institution of Excellence, Vijnana Bhavan, University of Mysore, Manasagangotri, Mysore, India.
  • College of Osteopathic Medicine, Lake Erie College of Osteopathic Medicine, Bradenton, Florida, USA.
  • NUS Center for Cancer Research, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.

ORCID-Profile: Kanchugarakoppal S Rangappa, Anupam Bishayee, Alan Prem Kumar, Gautam Sethi

Zitieren

APA

Ang, H. L., Mohan, C. D., Shanmugam, M. K., Leong, H. C., Makvandi, P., Rangappa, K. S., Bishayee, A., Kumar, A. P., & Sethi, G. (2023). Mechanism of epithelial‐mesenchymal transition in cancer and its regulation by natural compounds. Medicinal Research Reviews, 43(4), 1141-1200. https://doi.org/10.1002/med.21948

Vancouver

Ang HL, Mohan CD, Shanmugam MK, Leong HC, Makvandi P, Rangappa KS, et al. Mechanism of epithelial‐mesenchymal transition in cancer and its regulation by natural compounds. Medicinal Research Reviews. 2023;43(4):1141-1200. doi:10.1002/med.21948

BibTeX
@article{Ang2023,
  author = {Ang, Hui Li and Mohan, Chakrabhavi Dhananjaya and Shanmugam, Muthu K and Leong, Hin Chong and Makvandi, Pooyan and Rangappa, Kanchugarakoppal S and Bishayee, Anupam and Kumar, Alan Prem and Sethi, Gautam},
  title = {Mechanism of epithelial‐mesenchymal transition in cancer and its regulation by natural compounds},
  journal = {Medicinal Research Reviews},
  year = {2023},
  volume = {43},
  number = {4},
  pages = {1141--1200},
  doi = {10.1002/med.21948}
}
Kostenlos starten →